We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » Dealing with FDA and Their Inspection Enforcement Tools - Webinar Recording/ Transcript

Other Options

USB Audio Recording/Transcript - April 23, 2019

$287.00

USB Audio Recording/Transcript - April 23, 2019

$258.00

USB Audio Recording/Transcript - April 23, 2019

$244.00

USB Audio Recording/Transcript - April 23, 2019

$230.00

USB Audio Recording/Transcript - April 23, 2019

$215.00

Dealing with FDA and Their Inspection Enforcement Tools - Webinar Recording/ Transcript

$287.00
Webinar Recordings

Product Details

Dealing with FDA and Their Inspection Enforcement Tools

Successfully navigating inspections is essential to your relationship and reputation with the FDA. And, of course, it’s key to securing approval for your product and getting it to market.

Make the most of your next inspection with insights from a former Associate Chief Counsel for Enforcement at the FDA. 

Presentation Takeaways:

  • Best practices for answering FDA Form 483 observations
  • Strategies for avoiding warning letters and serious enforcement actions
  • Tips for building agency confidence in site operations
  • Tools for assessing company exposure to regulatory risk — including identifying hot-button issues for inspections
  • Knowledge of FDA factors that renders enforcement or escalations

Avoid escalation to injunctions by knowing how to respond to FDA enforcement actions.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing